feed,title,long_url,short_url
Benzinga,Opiant Pharma Starts Dosing In OPNT002 Mid-Stage Study For Alcohol Use Disorder,https://benzinga.com/general/biotech/22/01/25153598/opiant-pharma-starts-dosing-in-opnt002-mid-stage-study-for-alcohol-use-disorder,https://bit.ly/3Ivi9Q5
